Table I.
The demographic characteristics of patients and tumors.
| Clinicopathological factors | |
|---|---|
| Patients, n | 46 |
| Age, years | |
| Mean (SD) | 65.8 (6.2) |
| Median (range) | 66 (49–78) |
| Serum PSA level, ng/ml | |
| Mean (SD) | 13.2 (7.5) |
| Median (range) | 11.4 (4.4–33.9) |
| Prostatic weight, gm | |
| Mean (SD) | 27.5 (10.0) |
| Median (range) | 26.2 (11.8–60.8) |
| Gleason score, n (%) | |
| 6 | 17 (37) |
| 7 | 26 (56.5) |
| 8 | 1 (2) |
| 9 | 2 (4.5) |
| Pathological T stage, n (%) | |
| pT2a | 16 (35) |
| pT2b | 7 (15) |
| pT2c | 9 (20) |
| pT3a | 10 (21.5) |
| pT3b | 4 (8.5) |
| Cancer volume, cm3 | |
| Mean (SD) | 4.8 (3.9) |
| Median (range) | 3.7 (0.2–15.2) |
SD, standard deviation; PSA, prostate-specific antigen.